Archer Daniels Midland
- Market cap
- 39.20B
- P/E (TTM)i
- 22.22
- P/Bi
- 1.66
- EPSi
- 2.23
- Div yieldi
- 2.53%
- 52W posi
- 79%
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
- The number of reporting institutions decreased by 3 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 88.80% +0.02pp
- Institutions
- 1,365 -3
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
DivergingInstitutions added shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two are pointing in different directions.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Top holders as of 2026-06-30
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 48 buys · 2 sells
| Name | Role | Stake |
|---|---|---|
| Juan Luciano | Chairman, CEO & President | 0.45% |
| Christopher Cuddy | Senior VP & President of Carbohydrate Solutions | 0.07% |
| Gregory A. Morris | Senior VP and President of Agricultural Services & Oilseeds | 0.06% |
| Vikram Luthar | Chief Financial Officer | 0.03% |
| Monish Patolawala | Former Chief Financial Officer & Executive VP | 0.03% |
| Jennifer Weber | Chief Human Resources Officer & Chief Diversity Officer | 0.03% |
| Ian Pinner | Senior VP and Chief Strategy & Innovation Officer | 0.02% |
| Regina Jones | Senior Vice President | 0.02% |
| Ismael Roig | Senior VP, President of Europe, Middle East & Africa and President of Animal Nutrition | 0.01% |
| Carrie Nichol | Vice President | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-30 | Patrick Moore | Independent Director | Other Derivative Acquisition | +721 | -- |
| 2026-09-30 | Terrell Crews | Independent Director | Other Derivative Acquisition | +878 | -- |
| 2026-09-30 | Kelvin Westbrook | Independent Director | Other Derivative Acquisition | +721 | -- |
| 2026-09-30 | James Collins | Independent Director | Other Derivative Acquisition | +800 | -- |
| 2026-09-30 | Suzan Harrison | Independent Director | Other Derivative Acquisition | +800 | -- |
| 2026-09-30 | Michael Burke | Independent Director | Other Derivative Acquisition | +831 | -- |
| 2026-09-30 | Debra Sandler | Independent Director | Other Derivative Acquisition | +800 | -- |
| 2026-09-30 | Ellen de Brabander | Director | Other Derivative Acquisition | +721 | -- |
| 2026-09-30 | Michael McMurray | Director | Other Derivative Acquisition | +721 | -- |
| 2026-09-30 | Lei Schlitz | Independent Director | Other Derivative Acquisition | +721 | -- |
| 2026-09-30 | Theodore Colbert | Independent Director | Other Derivative Acquisition | +721 | -- |
| 2026-09-30 | David McAtee | Director | Other Derivative Acquisition | +721 | -- |
| 2026-09-08 | Patrick Moore | Independent Director | Other Derivative Acquisition | +615 | -- |
| 2026-09-08 | Terrell Crews | Independent Director | Other Derivative Acquisition | +412 | -- |
| 2026-09-08 | Kelvin Westbrook | Independent Director | Other Derivative Acquisition | +214 | -- |
| 2026-09-08 | James Collins | Independent Director | Other Derivative Acquisition | +79 | -- |
| 2026-09-08 | Suzan Harrison | Independent Director | Other Derivative Acquisition | +120 | -- |
| 2026-09-08 | Michael Burke | Independent Director | Other Derivative Acquisition | +121 | -- |
| 2026-09-08 | Debra Sandler | Independent Director | Other Derivative Acquisition | +183 | -- |
| 2026-09-08 | Ellen de Brabander | Director | Other Derivative Acquisition | +66 | -- |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 07:32:46 · For reference only, not investment advice and not tailored to your situation.